Morphic

+$1.51 (+3.15%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Morphic and other stocks, options, and ETFs commission-free!

About MORF

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas.

CEO
Praveen P. Tipirneni
Employees
89
Headquarters
Waltham, Massachusetts
Founded
2014

MORF Key Statistics

Market Cap
1.97B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
142.56K
High Today
$49.82
Low Today
$45.64
Open Price
$47.64
Volume
201.65K
52 Week High
$93.00
52 Week Low
$13.87

MORF Earnings

-$0.66
-$0.32
$0.02
$0.36
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.58 per share
Actual
-$0.63 per share

You May Also Like

FRI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure